MedPath

To study effect of Trikarshika ghanvati in treating gout ( vaatarakta)

Phase 2/3
Not yet recruiting
Conditions
Gout, unspecified. Ayurveda Condition: VATARAKTAM,
Registration Number
CTRI/2025/05/087320
Lead Sponsor
Shree Saptashrungi Ayurved Mahavidyalaya Kamal nagar Hirawadi Panchvati Nashik
Brief Summary

Primary Objective -

1.To study the effect of Trikarshika ghanvati in the management of vaatarakta.

Secondary objective-

1.To study the difference of the effect of Febuxostat and Trikarshika ghanvati in the management of vaatarakta.

Other Objective-

1.To review and study the literature of vaatarakta.

2.To review and study the literature of Gout.



Study-Randomised Control Trial

Intervention-

Group A- Trikarshika ghanvati 500 mg bd

Group B- Febuxostat 40 mg bd



Duration of Treatment- 30 days

Initial Assessment 0n 1 st day

Follow up- 15th ,30 th day



Data analysis

Data will be analysed using appropriate statistical methods to compare the effectiveness of intervention on the primary and secondary outcomes.



Ethical Consideration -

The study will be conducted in accordance with Ethical Guidelines and with informed consent from participants.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients having uric acid level between 6mg/dl to 10mg/dl.

Exclusion Criteria
  • Amavata (Rheumatoid Arthritis) 2.
  • Sandhigata vaata 3.
  • With H/O malignancy HIV trauma Cardiac disease Neurological disorders etc associated with gout 4.
  • Pregnant women and lactating mother.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in signs and symptoms of gout.30 days
Secondary Outcome Measures
NameTimeMethod
Where trial group stands in comparison with control group in reducing signs and symptoms of gout18 months

Trial Locations

Locations (1)

Shree Saptashrungi Ayurved Mahavidyalaya And Hospital

🇮🇳

Nashik, MAHARASHTRA, India

Shree Saptashrungi Ayurved Mahavidyalaya And Hospital
🇮🇳Nashik, MAHARASHTRA, India
Dr Divya Shriniwas Pogul
Principal investigator
8766573836
poguldivya@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.